Prices delayed by at least 15 minutes | Prices updated on 30 May 2025, 17.40 BST | Print
Renalytix PLC (RENX)
ORD 0.25PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Income statement
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal year ends | 30/06/2020 | 30/06/2021 | 30/06/2022 | 30/06/2023 | 30/06/2024 |
Turnover | 0 | 1 | 3 | 3 | 2 |
Expenses | 10 | 34 | 56 | 46 | 31 |
EBITDA | -10 | -34 | -53 | -42 | -29 |
EBIT | -10 | -36 | -53 | -42 | -29 |
Operating profit (reported) | -10 | -33 | -53 | -42 | -29 |
Operating profit (adjusted) | - | - | - | - | - |
Investment income | 0 | -9 | 10 | 0 | 0 |
Exceptional items | - | 6 | -2 | -4 | -5 |
Net interest | - | 0 | - | - | - |
Pre-tax profit | -10 | -36 | -45 | -46 | -33 |
Tax | 0 | -5 | 0 | 0 | 0 |
Net profit | -10 | -31 | -45 | -46 | -33 |
Minority interests | 0 | - | - | - | - |
Profit for financial year | -10 | -31 | -45 | -46 | -33 |
Ordinary dividends | - | - | - | - | - |
Retained profit | - | - | - | - | - |
Per share data | |||||
DPS p | - | - | - | - | - |
Normalized EPS p | -17.00 | -51.00 | -64.91 | -49.66 | -26.40 |
Reported EPS p | -17.00 | -43.00 | -67.00 | -55.00 | -31.00 |
Investment ratios | |||||
Operating margin | - | -21.87 | -17.91 | -12.41 | -12.62 |
DPS growth % | - | - | - | - | - |
Dividend cover x | - | - | - | - | - |
Norm EPS growth % | - | - | - | - | - |
Reported EPS growth % | - | - | - | - | - |
USD in millions except per share data.